News & Events
August 4-8, 2019. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California. AACC provides an unparalleled opportunity to connect with global leaders in laboratory medicine and to discover cutting edge technology and learn about vital research in the field. AACC is the meeting place for global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
July 08-10,2019. Dr. Mickey S. Urdea will attend and present at the 2019 IDRTalks (Infectious Disease Research and Response Network) at Colorado State University in Fort Collins, CO and speak on “Why Diagnostics Companies Fail: Lessons Learned.”
June 17-18, 2019. Dr. Mickey S. Urdea will attend the 27th International Biodetection Technologies: Biothreat and Pathogen Detection Conference in Bethesda, Maryland. This internationally recognized meeting is for experts in detection and identification of biological threats. This conference addresses the key topics in pathogen detection and presents the latest R&D and technological innovations in ready-to-market systems. In addition, this meeting will focus on the latest strategies to overcoming the hurdles to the identification of global biological threats and translational gaps in bringing technologies from lab to field. Stimulating discussions, perspectives of end-users, high quality case studies will be featured and the opportunity to network with the leading experts in biodefense from around the globe will be provided.
March 11-13, 2019 Mr. Richard M. Thayer will attend the Digital Health: Sensors, Wearables and IoT program of the Molecular Diagnostics Strategy and Outlook Executive Summit, part of the Molecular Medicine Tri-Conference in San Francisco, California. Molecular diagnostics along with healthcare in general are undergoing technology-driven revolution. Novel detection assays and sensors, digital biomarkers and machine learning approaches have become key drivers for innovation in drug development and patient care. This channel will feature the latest technology breakthroughs as well as partnering, regulatory and reimbursement solutions for implementation into value-based patient-centered care.
March 4-7, 2019 Dr. Mickey S. Urdea will participate in the CROI Conference in Seattle, Washington. The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. The CROI Foundation partners with the International Antiviral Society–USA (IAS–USA) for organization of the conference.
January 7 - 10, 2019. Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2019, more than 450 companies, both public and private, are set to deliver presentations to more than 9,000 attendees.
July 29-August 2, 2018. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 70th AACC 2018 Annual Meeting in Chicago, Illinois. The American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine and provides opportunities to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine; learn about cutting edge technology; and hear about important changes in the field.
May 15, 2018. Dr. Mickey S. Urdea, a diagnostics entrepreneur and founding partner at Halteres Associates, will present —Why Do Diagnostics Companies Fail?—to the QB3 & the Rosenman Institute at the University of California, San Francisco on May 15, 2018. Over the last decade, several diagnostics companies that initially appeared to be on a path to success ultimately failed. The Bill & Melinda Gates Foundation asked Halteres to study the phenomenon. Classifying 28 companies as "Successes," "Failures," and "Zombies," the firm found that key indicators of success or failure emerged as companies drove their concepts toward commercialization.
February 13-14, 2018. Mr. Richard M. Thayer will attend the Cambridge Healthtech Institute's Inaugural Healthcare IoT (Internet of Things) Conference in San Francisco, California. The healthcare industry is at the advent of a digital evolution, spurred by a growing community of web-enabled products and services including the Cloud, smart and connected devices, and a more health-conscious and tech-savvy population. Cambridge Healthtech Institute's Inaugural Healthcare Internet of Things aims to bring together the different constituents and stakeholders within the value chain to participate in interactive discussion panels and deliver cases studies and pilot programs that showcase the healthcare industry's collaborative efforts toward the adoption and implementation of IoT. If you are interested in catching up with Rich during this conference, please let us know.
February 11-16, 2018. Mr. Rich Thayer will attend the 25th CHI Molecular Medicine Tri-Conference in San Francisco, CA February 11-16, 2018. Since its debut in 1993, the annual Molecular Medicine Tri-Conference is considered the premiere event on molecular medicine and diagnostics and has become one of the world's leading international events in the field of drug discovery, development, and diagnostics. The Tri-Conference presents more than 500 speakers and unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma, and academia from around the world. If you are interested in catching up with Rich while he is at Tri-Con, please let us know.
January 8-11, 2018. Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California January 8-11, 2018. Thirty five years ago, J.P. Morgan launched Wall Street's premier investor conference focused exclusively on companies defining the healthcare industry. Today, the JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2018, more than 400 companies, both public and private, are set to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting. If you are interested in catching up with Mickey and Rich while they are at JPM, please let us know.
December 4-9, 2017. Dr. Mickey S. Urdea will attend the 19th ICASA (International Conference on AIDS and STIs in Africa) in Abidjan, Cote D'Ivoire. Dr. Urdea will also present “Insights From Business Modeling of Infectious Disease Diagnostic Products From The Perspective of Manufacturers and Procurers” at a satellite symposium scheduled for December 3, 2017. The convening of the International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA 2017) is the premier gathering for those working in the field of HIV, as well as leaders, people living with HIV, and others committed to ending the epidemic. This is a tremendous opportunity for researchers from around the world to share the latest scientific advances in the field, learn from one another's expertise, and develop strategies for advancing all facets of collective efforts to treat and prevent HIV.
November 16-18, 2017. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the AMP 2017 Annual Meeting November 16-18, 2017 in Salt Lake City, Utah. The Association for Molecular Pathology (AMP) provides structure and leadership to the emerging field of molecular diagnostics. AMP is a not-for-profit scientific society that advances the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy to enable highest quality health care.
July 30 - August 3, 2017. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, California. The American Association of Clinical Chemists (AACC) brings together the world of laboratory medicine to exchange best practices, learn about the latest biomedical science, and network with like-minded professionals from across the globe.
July 23-26, 2017. Dr. Mickey S. Urdea will attend the 9th IAS Conference on HIV Science in Paris, France. Organized by the International AIDS Society (IAS) in partnership with the ANRS (France Recherche Nord & Sud Sida-HIV Hèpatites), IAS 2017 will serve as the platform to showcase the key research of the year. This biennial gathering is the largest open scientific conference on HIV and AIDS related issues - bringing together a broad cross-section of more than 6,000 professionals from around the world to meet and examine the latest scientific developments in HIV-related research with a focus on moving science into practice and policy.
May 31 - June, 2017. Dr. Mickey S. Urdea and Dr. Laura T. Mazzola will present and coordinate workshops at the 1st South African HIV Self-Testing Symposium in Johannesburg, South Africa. This meeting is convened by the South African National Department of Health through secretariat assistance from the Wits Reproductive Health and HIV Institute and the Bill & Melinda Gates Foundation.
May 16 - 17, 2017. Rich Thayer is an invited speaker at “The Maloney Entrepreneur's Workshop: The Journey From Discovery to Reality” at Washington State University Pullman Campus College of Veterinary Medicine, Pullman, WA.
Dr. Mickey Urdea of Halteres Associates was quoted in an April 2017 Chemistry World article
March 30-31, 2017. Geneva Switzerland, WHO Headquarters — Dr. Mickey Urdea of Halteres Associates, participated in the “Joint WHO/UNITAID Consultation with Diagnostic Manufacturers on Global Demand Forecasts for Diagnostics”
February 19-24, 2017. San Francisco CA — 24th CHI Molecular Tri-Con 2017, Dr. Urdea spoke at the meeting.
February 14, 2017. Dr. Mickey Urdea of Halteres Associates, was a panelist on The Association for Pathology Informatics (API) and Sunquest Information Systems “Consumerism in Diagnostics: Retail Testing and the Future of Providers” Webcast session on February 14th at 2:00 pm (ET).
February 12, 2017. Dr. Mickey Urdea of Halteres Associates, attended the Bill & Melinda Gates Foundation convening on HIV Self-Testing on Sunday February 12, 2017.
February 12, 2017. Dr. Mickey Urdea of Halteres Associates, attended the UNITAID pre-CROI event, Partnership for ART Optimisation at the Washington State Convention Center.
November 10-12, 2016. Charlotte, NC — Association for Molecular Pathology (AMP) Annual meeting, Halteres attended
July 18-22, 2016. Durban, South Africa — 21st International AIDS Conference, Halteres attended
June 13-17, 2016. Montreal, Quebec — Global Health Diagnostics Course, McGill University, Halteres attended
March 6-11, 2016. San Francisco, CA — 23rd CHI Molecular Tri-Conference, Halteres hosted a “Point-of-Care Diagnostics” seminar
March 7, 2016. San Francisco, CA — UCSF Symposium, “Preparedness for the Zika Virus: A Public Health Emergency”, Halteres attended
November 9-10, 2015. Bethesda, MD — IEEE EMBS Strategic Conference on Point of Care Technologies for Precision Medicine. Halteres presenting at the “Point of Care Business Models and Future Trends” session.
July 29, 2015. Atlanta. GA — American Association of Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo. Halteres presented at “Convergence of Global Point-of-Care Diagnostic Needs” symposium.
June 8, 2015. Geneva, Switzerland—Halteres participated in the WHO Global Consultation on Diagnostics Interoperability Standards Meeting
May 29, 2015. San Francisco, CA — Mickey Urdea awarded the UCSF 150th Anniversary Alumni Excellence Award. Dr. Urdea was one of 150 award recipients.
May 18-19, 2015. Geneva, Switzerland—Halteres participated in the Point-of-Care Diagnostics Evaluations: Partners Synergy Meeting (II), co-sponsored by UNITAID and WHO
April 21, 2015. San Francisco, CA — Halteres presented at the Ebola Innovation Summit: 21st Century Tools to Tackle Ebola and Improve Health.
March 28, 2015. Santa Clara, CA — Halteres attended EPPICon 2015. Dr. Urdea was a panel moderator for: Innovations in Devices/Diagnostics
November 2014. Jaipur, India—Halteres attended the CHAI Supplier/Buyer Summit
October 13-15, 2014. Barcelona, Spain—Halteres presented at the WHO Working Group on HIV Incidence Assays Meeting, Presentation: Use Cases for HIV Incidence Assays
June 23-25, 2014. Dar es Salaam, Tanzania—Halteres participated in the African Society of Medicine HIV Consultative Meeting
Feb 14, 2014. San Francisco, CA—Halteres presented at the Molecular Tri Conference “Point of Care Testing (POCT): The Time is Now” session. Presentation: Why emerging markets are driving advancements in POCT and how developed markets are likely to benefit